The hallucinogenic aspect of the drug can make MDMA users feel euphoric while also leading to hallucinations and distortions of the experiences of time and space. MDMA, more commonly referred to as ecstasy or Molly, is a synthetic drug that is both a stimulant and a hallucinogen. Inside the chemical name is “amphetamine,” as MDMA belongs to this class of drugs known as central nervous system stimulants. Mixing MDMA and weed is not advisable due to the potential negative drug interactions. We implemented the approach of de Chaisemartin and d’Haultfoeuille23 using regression analysis. All regressions controlled for 2 state-level economic indicators (ie, state poverty rates and real gross domestic product).
MDMA + other recreational drugs
All regressions also included state indicators to control for time-invariant state-level characteristics and year indicators to control for secular changes or shocks in outcomes that are common to all states. Detailed descriptions of the variables in the regression are provided in eTable 3 in Supplement 1. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines.
Mixing Ecstasy (Molly) & Weed: Effects & Risks
Where significant main effects were observed, pairwise comparisons were conducted using Bonferroni-adjusted t-tests. Mauchley’s test of sphericity was violated in the low-dose condition for within-subjects effect of delay, but application of the Huynh–Feldt adjustment did not alter the results. The results can therefore be viewed as being robust against violations of the sphericity assumption. To further substantiate this point, data were re-analyzed using a two-factor nonparametric randomization test of scores using NPFact version 1.0 (May et al, 1993). In all cases the results of the randomization tests agreed with the ANOVA results, so for ease of interpretation only the ANOVA tests are shown, which reflect the Huynh–Feldt correction. You can, of course, test your drugs at home using kits you can purchase online but they may not always identify all the present compounds.
Co-administration of THC and MDMA (‘Ecstasy’) Synergistically Disrupts Memory in Rats
MDMA first became popular in nightclubs, but people now take it in a wide range of settings. Researchers are also studying MDMA as a treatment for depression and https://sober-home.org/alcohol-withdrawal-delirium-causes-symptoms-and/ post-traumatic stress disorder (PTSD) in supervised clinical research trials. Read more about MDMA research on the National Institute of Mental Health website.
Human studies of psychedelics or related compounds in CUD
MDMA (an abbreviation of 3,4-methylenedioxymethamphetamine), also called “Molly” or “Ecstasy,” is a lab-made (synthetic) drug that has effects similar to stimulants like methamphetamine. It is typically sold illicitly as colorful tablets with imprinted logos, capsules, powder, or liquid. Some researchers and organizations consider MDMA to be a psychedelic drug because it can also mildly alter visual and time perception. MDMA’s effects may include feeling more energetic and alert and having an increased sense of well-being, warmth, and openness toward others. Clinical studies suggest that MDMA may increase the risk of long-term or permanent problems with memory and learning.
Attenuation of MDMA-induced hyperthermia by ethanol in rats depends on ambient temperature
Thus, after chronic use, the absence of THC may unmask this enhanced stress response, manifesting as withdrawal symptoms, contribute to the development of negative reinforcement, and be mitigated by substance use relapse. The stimulant effects of the drug, which enable the user to dance for extended periods, combined with the hot, crowded conditions usually found at raves can lead to dehydration, hyperthermia (dangerous increase in body temperature), and heart or kidney failure. As the rave and club scene expanded to metropolitan and suburban areas across the country, MDMA use and distribution increased as well.
Harm reduction strategies for those having sex while using psychoactive substances may include helping people recognise the need to carry condoms and lube as well as developing strategies for partner selection and negotiating condom use while inebriated. This is especially important if an individual feels he or she is acquiring positive sexual effects from use of such substances. In addition, both substance and sexual education programmes should address reasons why individuals engage in these behaviours (i.e. the pleasure derived from substance use and sex). Pleasure is an important factor in the decision to use substances or engage in sexual activity yet these discussions are often excluded from health education.
- Psychedelics have garnered interest as a therapeutic class in other substance use disorders, and self-report surveys suggest they may result in positive outcomes for CUD.
- However, one experienced symptom of emotional instability, anxiety, and depression which lasted for several weeks.
- While there was no control group, compared to before treatment participants had a statistically significant reduction in cannabis use following treatment, and improvement in self-reported confidence in resisting the urge to use cannabis.
- Ecstasy, usually taken in pill or tablet form, reached peak popularity in the 1990s.5 Although it is still around today, other “branded” versions of MDMA, like Molly, are more commonly circulated because they are mistakenly believed to be purer and therefore safer.
- Comparisons of self-reported sexual effects specific to sexual encounters by drug.
Although MDMA alone had no effect, it exacerbated the impairment due to THC when the drugs were co-administered. Experiment 3 (high doses) examined the effects of 1 mg/kg THC and 5 mg/kg MDMA alone and together. Both drugs significantly impaired memory when given alone, although the impairment due to MDMA was less than that caused by THC. When co-administered at these doses, the drugs caused a major disruption of behavior and this precluded ascribing a mnemonic cause to poor performance on the double Y-maze task. Taken together, these experiments demonstrate a synergistic disruption of working memory by acute co-administration of THC and MDMA. A plot of unadjusted differences in outcomes between states with and without recreational or medical cannabis laws against the time since opening of cannabis dispensaries is shown in eFigure 2 in Supplement 1.
Information provided by NIDA is not a substitute for professional medical care or legal consultation. Review of studies for inclusion was carried out independently by two reviewers and disagreements were resolved by discussion. The same eligibility criteria were applied to the title and abstract screen as to the full-text screen.
Most people experience a strong urge to take another dose as the effects begin to wear off. The comedown from LSD usually lasts around 24 hours and can include feelings of depression, panic, and paranoia. Some people report having lingering comedown symptoms for days and even months after. Some say you get an experience that’s equal parts of the good effects of both substances. From that same survey, users who took lithium, a different class of antidepressant, also had more intense trips from LSD, but they weren’t pleasant.
As the method of de Chaisemartin and d’Haultfoeuille23 evaluates only 1 policy at a time, the effects of medical and recreational cannabis laws were estimated in separate regressions. Also, the opioid policies were used only to identify valid control states for the analysis; thus, their effects were not estimated by the regressions. For comparison, we also used traditional DD analyses to examine the association of cannabis law implementation with opioid outcomes. In addition to examining the association of cannabis law implementation with overall opioid overdose mortality, we conducted subgroup analyses in which we assessed these associations with opioid mortality by the type of opioid involved in overdose. Acute and chronic psychosis is an adverse effect of particular concern, as exemplified in the case study reviewed above. A systematic review by Studerus et al. including psychedelic-assisted therapy studies from 1999 to 2008 noted that among participants receiving psilocybin, 27% experienced fear and 17% paranoia.
In conclusion, this study found that acutely co-administered THC and MDMA in rats, within a dose range relevant to human consumption, produced an impairment of working memory greater than that of either MDMA or THC alone. It was particularly notable that subthreshold doses of the two individual drugs produced an observable impairment in working memory when combined. While this acute effect was robust, there was no indication from this study whether the impairment would be long lasting, or extend to other cognitive processes. The neurochemical mechanisms underlying this result are presently a matter of speculation but represent an interesting direction for further research. Although some individuals may choose to mix MDMA and weed, it is crucial to recognize that this practice can carry significant health risks. The effects and safety of this combination are highly unpredictable and may lead to undesirable consequences.
Very little research has examined their effect on cognitive function or behavior when combined. The present study used a double Y-maze task to examine the acute effect of MDMA and Δ9-tetrahydrocannabinol (THC, the principal psychoactive ingredient of cannabis) on mnemonic function in rats, at a range of doses representative of common human use. Experiment 1 (low doses) examined the effect of 0.25 mg/kg THC and 1.25 mg/kg MDMA alone and together. At these doses MDMA or THC given alone had no effect on working memory, but the co-administered drugs significantly disrupted working memory. Experiment 2 (medium doses) examined the effect of 0.5 mg/kg THC and 2.5 mg/kg MDMA given alone or together.
Lasting behavior change can be triggered by an experience that is vivid, benevolent, mystical, and/or characterized by important insights. These “mystical experiences” are thought to provide profound alterations in perception along with a sense of meaningfulness, insightfulness, and unity. This state, achieved with support of psychedelics, is thought to be more malleable, flexible, sensitive to the environment, and open to change. Such experiences have also been reported with non-classic psychedelics, including “dissociative” compounds such as ketamine, or the “entactogen” MDMA. The therapeutic effects from these experiences can be enduring, and it is conceptualized that during the psychedelic experience a therapeutic window in the mind is temporarily opened which facilitates gained insight and emotional release. In conjunction with psychotherapeutic support, this insight can potentially lead to a healthy revision of outlook and lifestyle (47).
Marijuana is made up of dried leaves, stems, and seeds of the cannabis Sativa, Indica, and Ruderalis plants. The two active components in marijuana are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the psychoactive component of weed that produces the high people experience. However, this doesn’t mean that it can’t cause unpleasant effects when taken in large doses.
The competition can diminish the effects of the acid, but it may work differently for other antidepressants. The comedown effects often lead people to use other drugs to moderate these effects, either in combination with ecstasy or during the withdrawal period. One of the most common drugs used with ecstasy, as a way to moderate the strong effects of the drug is marijuana. Ecstasy, usually taken in pill or tablet form, reached peak popularity in the 1990s.5 Although it is still around today, other “branded” versions of MDMA, like Molly, are more commonly circulated because they are mistakenly believed to be purer and therefore safer. This can occur in illicit drug markets where the purity and quality of substances are not regulated.
The clues we have from existing literature indicate that while it’s probably safe, there’s insufficient clinical research to confirm or dispel it. Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future. Exercise caution when using marijuana or MDMA, and start with low doses until you understand your tolerance levels. Design, Setting, and https://sober-home.org/ Participants This quasiexperimental, generalized difference-in-differences analysis used annual state-level data between January 2006 and December 2020 to compare states that legalized recreational or medical cannabis vs those that did not. DoubleBlind Magazine does not encourage or condone any illegal activities, including but not limited to the use of illegal substances. We are not a substitute for medical, psychological, or psychiatric diagnosis, treatment, or advice.
However, we believe in providing accessible and accurate information to reduce the harm that can occur when using. “It’s actually almost a joke within some psychedelic communities, a sort of classic mistake as you’re coming down off of LSD to be like, ‘Oh, I’m gonna smoke some pot and go to bed and then you do and now you’re like tripping tripping again,” Gomez said. If you’re not expecting that, it can be an overwhelming, uncomfortable experience.
With its distal door closed, box C appeared identical to each start box, so the rat had to learn to use external visual cues to solve this first ‘Y’ maze. If the rat entered the wrong arm, no reward was available but no intervention took place; rather, the rat was allowed to proceed until it located the reward in box C. When the rat had entered box C and collected the reward, its retreat back into the first ‘Y’ was blocked by placing a door behind the rat (at the proximal end of C), and the distal door of box C was then removed. Broken lines represent the locations of removable barriers that were used to restrict access to different areas of the maze.